Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma

Liu,Guijuan; Ren,Xingbin; Gao,Chunhai; Zhang,Wei

doi:10.3892/mmr.2015.3602

Acylglycerol kinase promotes the proliferation and cell cycle progression of oral squamous cell carcinoma

Authors:
- Guijuan Liu
- Xingbin Ren
- Chunhai Gao
- Wei Zhang
View Affiliations

Affiliations: Cytology Laboratory, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China, Clinical Laboratory, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China, Second Department of Trauma Orthopedics, Linyi People's Hospital, Linyi, Shandong 276003, P.R. China
Published online on: April 8, 2015 https://doi.org/10.3892/mmr.2015.3602
Pages: 2225-2230

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cell proliferation is a major underlying cause of mortality amongst patients with oral squamous cell carcinoma (OSCC); however, the underlying mechanisms have remained to be elucidated. Acylglycerol kinase (AGK) is a multisubstrate lipid kinase, which is known to be associated with the progression of various types of human cancer. The present study aimed to investigate the role of AGK in cell proliferation and cell cycle progression in OSCC. The expression levels of AGK were detected in cancerous and adjacent normal tissue samples from four patients with OSCC undergoing surgical resection, and in OSCC cell lines, using the polymerase chain reaction (PCR) and western blot analysis. The effects of AGK on the proliferation and cell cycle progression of OSCC cells were assessed using a short hairpin RNA lentivirus or expressed‑plasmid transfection. In addition, the expression levels of cyclin D1 and p21, as well as cell proliferation- and cell cycle‑associated proteins were detected by PCR and western blotting. The results of the present study demonstrated that the expression levels of AGK were significantly higher in the cancerous tissues and OSCC cell lines, compared with the adjacent normal tissues and control cells, respectively. Furthermore, MTT and colony formation assays, in addition to flow cytometric analysis were conducted, in order to assess the role of AGK in cell proliferation and cell cycle progression. The cell proliferation and cell cycle progression of an established OSCC cell line were demonstrated to be decreased following AGK knockdown, and enhanced by AGK overexpression in vitro. Aberrant AGK expression in OSCC was shown to be associated with cell proliferation and cell cycle progression. The results of the present study provide evidence that AGK may promote cell proliferation and cell cycle progression in OSCC.

View Figures

View References

1	Jiang Q, Yu YC, Ding XJ, Luo Y and Ruan H: Bioinformatics analysis reveals significant genes and pathways to target for oral squamous cell carcinoma. Asian Pac J Cancer Prev. 15:2273–2278. 2014. View Article : Google Scholar : PubMed/NCBI
2	Rigual NR, Shafirstein G, Frustino J, et al: Adjuvant intraoperative photodynamic therapy in head and neck cancer. JAMA Otolaryngol Head Neck Surg. 139:706–711. 2013. View Article : Google Scholar : PubMed/NCBI
3	Epand RM, Shulga YV, Timmons HC, et al: Substrate chirality and specificity of diacylglycerol kinases and the multisubstrate lipid kinase. Biochemistry. 46:14225–14231. 2007. View Article : Google Scholar : PubMed/NCBI
4	Bektas M, Payne SG, Liu H, Goparaju S, Milstien S and Spiegel S: A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells. J Cell Biol. 169:801–811. 2005. View Article : Google Scholar : PubMed/NCBI
5	Spiegel S and Milstien S: Critical role of acylglycerol kinase in epidermal growth factor-induced mitogenesis of prostate cancer cells. Biochem Soc Trans. 33:1362–1365. 2005. View Article : Google Scholar : PubMed/NCBI
6	Sherr CJ and Roberts JM: CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
7	Yong ST and Wang XF: A novel, non-apoptotic role for Scythe/BAT3: A functional switch between the pro- and anti-proliferative roles of p21 during the cell cycle. PLoS One. 7:e380852012. View Article : Google Scholar : PubMed/NCBI
8	Hong S, Li X, Zhao Y, Yang Q and Kong B: 53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathway. Oncol Rep. 27:1251–1257. 2012.PubMed/NCBI
9	Weinberg RA: The retinoblastoma protein and cell cycle control. Cell. 81:323–330. 1995. View Article : Google Scholar : PubMed/NCBI
10	Wang X, Lin C, Zhao X, et al: Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Mol Cancer. 13:1062014. View Article : Google Scholar : PubMed/NCBI
11	Cui Y, Lin C, Wu Z, et al: AGK enhances angiogenesis and inhibits apoptosis via activation of the NF-κB signaling pathway in hepatocellular carcinoma. Oncotarget. 5:12057–12069. 2014.PubMed/NCBI
12	Chen X, Ying Z, Lin X, et al: Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells. J Clin Invest. 123:2576–2589. 2013. View Article : Google Scholar : PubMed/NCBI
13	Nouh MA, Wu XX, Okazoe H, et al: Expression of autotaxin and acylglycerol kinase in prostate cancer: Association with cancer development and progression. Cancer Sci. 100:1631–1638. 2009. View Article : Google Scholar : PubMed/NCBI
14	Knudsen KE, Diehl JA, Haiman CA and Knudsen ES: Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene. 25:1620–1628. 2006. View Article : Google Scholar : PubMed/NCBI
15	Bali A, O’Brien PM, Edwards LS, Sutherland RL, Hacker NF and Henshall SM: Cyclin D1, p53 and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Clin Cancer Res. 10:5168–5177. 2004. View Article : Google Scholar : PubMed/NCBI
16	Ratschiller D, Heighway J, Gugger M, et al: Cyclin D1 overexpression in bronchial epithelia of patients with lung cancer is associated with smoking and predicts survival. J Clin Oncol. 21:2085–2093. 2003. View Article : Google Scholar : PubMed/NCBI
17	Comstock CE, Augello MA, Goodwin JF, et al: Targeting cell cycle and hormone receptor pathways in cancer. Oncogene. 32:5481–5491. 2013. View Article : Google Scholar : PubMed/NCBI
18	Baldin V, Lukas J, Marcote MJ, Pagano M and Draetta G: Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812–821. 1993. View Article : Google Scholar : PubMed/NCBI
19	Motokura T and Arnold A: Cyclin D and oncogenesis. Curr Opin Genet Dev. 3:5–10. 1993. View Article : Google Scholar : PubMed/NCBI
20	Carlos de Vicente J, Herrero-Zapatero A, Fresno MF and Lόpez-Arranz JS: Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol. 38:301–308. 2002. View Article : Google Scholar : PubMed/NCBI
21	Masamha CP and Benbrook DM: Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Cancer Res. 69:6565–6572. 2009. View Article : Google Scholar : PubMed/NCBI
22	Seo JH, Jeong ES and Choi YK: Therapeutic effects of lentivirus-mediated shRNA targeting of cyclin D1 in human gastric cancer. BMC Cancer. 14:1752014. View Article : Google Scholar : PubMed/NCBI
23	Wu J, Zhong D, Fu X, Liu Q, Kang L and Ding Z: Silencing of Ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progression. Int J Mol Sci. 15:5570–5581. 2014. View Article : Google Scholar : PubMed/NCBI
24	Li W, Sun S, Chen Y, Yu H, Chen ZY and Li H: Disrupting the interaction between retinoblastoma protein and Raf-1 leads to defects in progenitor cell proliferation and survival during early inner ear development. PLoS One. 8:e837262013. View Article : Google Scholar
25	Xu C, Wu C, Xia Y, et al: WT1 promotes cell proliferation in non-small cell lung cancer cell lines through up-regulating cyclin D1 and p-pRb in vitro and in vivo. PLoS One. 8:e688372013. View Article : Google Scholar : PubMed/NCBI
26	Nojiri S and Joh T: Albumin suppresses human hepatocellular carcinoma proliferation and the cell cycle. Int J Mol Sci. 15:5163–5174. 2014. View Article : Google Scholar : PubMed/NCBI
27	Rego MA, Harney JA, Mauro M, Shen M and Howlett NG: Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor. Oncogene. 31:366–375. 2012. View Article : Google Scholar